Vnitr Lek 2005, 51(1):101-105

Liver disease at alpha-1-antitrypsin deficiency

L. Husová1,*, M. Dastych jr.1, E. Kunertová2, P. Husa3, K. Dvořák4, M. Votava4
1 Interní gastroenterologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Petr Dítě, DrSc.
2 Interní oddělení nemocnice Břeclav, přednosta prim. MUDr. Jitka Siegelová
3 Klinika infekčních chorob Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta doc. MUDr. Petr Husa, CSc.
4 Patologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jirka Mačák, CSc.

Alpha-1-antitrypsin deficiency is a hereditary disease. Most often it affects lungs and liver. It can manifest itself as cholestasis in the newborn period or later as chronic hepatitis, liver cirrhosis, and also pulmonary emphysema. In this article a case report of a 21-year-old woman with alpha-1-antitrypsin deficiency determined by liver tests during a viral disease with high fevers treated by antibiotics and paracetamol has been described. Histology proved no changes in liver except PAS positive granules in hepatocytes. Examinations proved alpha-1-antitrypsin deficiency and PiZZ phenotype in the patient. Her medical history revealed asthma bronchiale present since her child's age. Following examination of her family's medical history revealed alpha-1-antitrypsin deficiency in her mother and her sister, PiMZ phenotype. However, neither one of them suffered from liver or pulmonary disease.

Keywords: alpha-1-antitrypsin deficiency; chronic hepatitis; liver cirrhosis; pulmonary emphysema

Received: January 15, 2004; Accepted: March 23, 2004; Published: January 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Husová L, Dastych M, Kunertová E, Husa P, Dvořák K, Votava M. Liver disease at alpha-1-antitrypsin deficiency. Vnitr Lek. 2005;51(1):101-105.
Download citation

References

  1. Schneiderka P. Biochemické vyšetření. In: Ehrmann J et al. Icterus - diferenciální diagnostika. Praha: Grada Publishing 2003: 45-64.
  2. Hauftová D, Ehrmann J. Metabolická jaterní onemocnění. In: Ehrmann J et al. Icterus - diferenciální diagnostika. Praha: Grada Publishing 2003: 179-189.
  3. Eriksson, S. Alpha-1-antitrypsin deficiency. J Hepatol 1999; 30 (S1): 34-39. Go to PubMed...
  4. Trunečka P. Kongenitální fibróza jater a vzácné metabolické choroby. In: Postgraduální kurs subkatedry gastroenterologie IPVZ. Sborník přednášek. Praha: Institut postgraduálního vzdělávání ve zdravotnictví 2000:157-161.
  5. Sveger T, Eriksson S. The liver in adolescents with alpha-1-antitrypsin deficiency. Hepatology 1995; 2(22): 514-517. Go to original source...
  6. Rosen HR. Alpha-1-antitrypsin deficiency and other metabolic liver diseases. In: Friedman, LS, Keeffe EB. Handbook of liver disease. London: Churchil Livingstone 1998: 255-265.
  7. De Tommaso AM, Rossi CL, Escanhoela CA et al. Diagnosis of alpha-1-antitrypsin deficiency by DNA analysis of children with liver disease. Arquivos de gastroenterologia 2001; 1(38): 63-68. Go to original source... Go to PubMed...
  8. Perthutter DH. Alpha-1-antitrypsin deficiency. Current Treatment Options in gastroenterology 2000; 3(6): 451-456. Go to original source... Go to PubMed...
  9. Pratschke J, Steinmüller T, Bechstein WO et al. Orthotopic liver transplantation for hepatic associated metabolic disorders. Clin Transplantation 1998; 12: 228-232. Go to original source... Go to PubMed...
  10. De Serres FJ. Worldwide racial and ethnic distribution of alpha-1-antitrypsin deficiency: Summary of and analysis of published genetic epidemiologic surveys. Chest 2002; 5(122): 1818-1829. Go to original source... Go to PubMed...
  11. Cosme A, Ojeda E, Torrado J et al. Liver alterations due to alpha-1-antitrypsin deficiency in adults. Study of 5 patients and analysis of the cases reported in the Spanish literature. Gastroenterologia y hepatologia 2003; 4(26): 251-256. Go to original source... Go to PubMed...
  12. Lima LC, Matte U, Leistner S et al. Molecular analysis of the Pi*Z allele in patients with liver disease. American Journal of Medical Genetics 2001; 4(104): 287-290. Go to original source... Go to PubMed...
  13. Carrell RW, Lomas DA. Alpha-1-antitrypsin deficiency - a model for conformational diseases. N Engl J Med 2002; 1(346): 45-53. Go to original source... Go to PubMed...
  14. Vogel W, Braunsteiner T, Dietze O et al. Pathogenesis of liver disease alpha-1-antitrypsin deficiency. Scandinavian J Gastroeterol 1990; 5(17): 100-103.
  15. Eriksson S. Alpha-1-antitrypsin deficiency. J Hepatol 1999; 30: 34-39. Go to PubMed...
  16. Lok ASF, Ghany MG, Gerber MA. A young woman with cirrhosis. Autoimmune hepatitis vs. alpha-1-antitrypsin deficiency. Hepatology 1994; 5(19): 1302-1306. Go to original source...
  17. Sharp HL. Wherefore are thou liver disease associated with alpha-1-antitrypsin deficiency? Editorial. Hepatology 1995; 2(22): 666-667. Go to original source...
  18. Leonis MA, Balisteri WF. Inherited metabolic disorders of the liver. In: Feldman M, Friedman LS, Sleisenger MH et al. Fordtran's Gastrointestinal and liver disease: pathophysiology, diagnosis, management. II. 7th ed. Philadelphia: Saunders 2002: 1240-1277.
  19. Mrskoš A, Kozák L, Pospíšilová J et al. Alpha-1-antitrypsin deficiency: Simple, inexpensive newborn mass screening method. Klin Biochem Metab 2002; 4(10): 191-194.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.